Personalized Management of Autoimmune Diseases With AI-Guided (GenAIS TM) Dietary Supplementation

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

June 10, 2024

Conditions
Autoimmune Diseases
Interventions
OTHER

Control group

Participants receive supplement prescriptions from a physician based on current standard practices, which include biochemical markers, genetic data, and metabolic profiles.

OTHER

AI-Guided Group

Participants receive supplement prescriptions determined by GenAIS, an AI system which considers genetic data, metabolic profiles, biochemical markers, and patient history.

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk

Sponsors
All Listed Sponsors
collaborator

Triangel Scientific

INDUSTRY

collaborator

Center of New Medical Technologies

OTHER

lead

S.LAB (SOLOWAYS)

OTHER

NCT06470412 - Personalized Management of Autoimmune Diseases With AI-Guided (GenAIS TM) Dietary Supplementation | Biotech Hunter | Biotech Hunter